Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Orally disintegrating tablet

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44364   clinical trials with a EudraCT protocol, of which   7388   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    6 result(s) found for: Orally disintegrating tablet. Displaying page 1 of 1.
    EudraCT Number: 2012-004388-34 Sponsor Protocol Number: 000088 Start Date*: 2013-03-06
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A Double-blind, Randomised, Parallel-group Trial Investigating Sleep Behaviour and Daytime Performance in Nocturia Patients Treated with Desmopressin Orally Disintegrating Tablets as compared to Pl...
    Medical condition: Nocturia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-001045-12 Sponsor Protocol Number: NO21125 Start Date*: 2016-07-20
    Sponsor Name:F. Hoffmann-La Roche AG
    Full Title: A Phase II Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children with Newly Diagnosed Brainstem Gliomas.
    Medical condition: Intrinsic Brainstem Glioma
    Disease: Version SOC Term Classification Code Term Level
    19.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10006143 Brain stem glioma PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2016-003851-31 Sponsor Protocol Number: 000233 Start Date*: 2017-08-24
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, with Desmopressin Orally Disinte...
    Medical condition: Nocturia due to Nocturnal Polyuria
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004857 10064016 Nocturnal polyuria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) HU (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2009-011411-21 Sponsor Protocol Number: BVF-324-302 Start Date*: 2009-07-17
    Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd
    Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation LLT
    Population Age: Adults Gender: Male
    Trial protocol: HU (Prematurely Ended) BG (Prematurely Ended) CZ (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2017-000808-22 Sponsor Protocol Number: 000278 Start Date*: 2017-11-13
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: An Open-label Trial Investigating the Association Between Nocturia and Sleep During 12 Weeks of Treatment with Desmopressin Orally Disintegrating Tablet (ODT) for Nocturia due to Nocturnal Polyuria...
    Medical condition: Nocturia due to Nocturnal Polyuria
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000017861 10064016 Nocturnal polyuria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2009-011410-18 Sponsor Protocol Number: BVF-324-301 Start Date*: 2009-07-29
    Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd
    Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation LLT
    Population Age: Adults Gender: Male
    Trial protocol: BE (Completed) DE (Prematurely Ended) FR (Completed) SE (Prematurely Ended) ES (Completed) GB (Prematurely Ended) NL (Prematurely Ended) AT (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Nov 16 11:36:42 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA